MedTrace Logo

Green Tea in Breast Cancer Patients

NCT00949923 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2018-03-30

No results posted yet for this study

Summary

Prognostic factors for breast cancer beyond stage at diagnosis and tumor characteristics have not been well studied. Of special interest are lifestyle factors that can be modified by women after diagnosis to increase disease-free survival. Green tea is rich in polyphenols consisting primarily of epicatechins, epigallocatechin, epicatechin gallate, and epigallocatechin gallate (EGCG). The investigators hypothesize that there will be a reduction in proliferation and/or an increase in apoptosis in association with short-term EGCG treatment.

Conditions

  • Incident Breast Cancer

Interventions

DIETARY_SUPPLEMENT

tea capsule

3 tea capsules daily for 3 weeks

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Principal Investigators

  • Anna Wu, PhD · University of Southern California

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-07
Primary Completion
2010-12-14
Completion
2016-06-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00949923 on ClinicalTrials.gov